Trump has unveiled a deal with Regeneron aimed at lowering US healthcare costs under the most-favored-nation push. The company will cut prices for its drugs on Medicaid, and Praluent, a cholesterol medicine, is set to be sold for $225 on Trump’s discounted drug website. Regeneron also pledges major investment in US research and development.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
